Shire Sues Sandoz Over Planned Generic Intuniv
The suit is the latest in a string Shire has launched against generics companies over the drug, following one against Mylan Pharmaceuticals Inc. on April 20 and several others last year.
According to the latest suit, Sandoz notified Shire of its abbreviated new drug application for generic Intuniv on March 14. Shire claims that the application...
To view the full article, register now.